Skip to content

Licox Cmp Monitor-AC3.1, Licox Imc Oxygen Catheters-CC1, CC1.SB Luicox Imc Introducer Kits-Im, IM2, IM3, II1 Licoximc Tempe

by Integra Neurosciences

510(k) K002765

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

3 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK002765 Date24 Nov 2000ClearedStatusActive

Recalls

3 recalls · FDA

    • Terminated Z-0831-2015 FDA Class II initiated 7 Nov 2014

    Due to a complaint, it was determined that multiple lots of Licox catheters manufactured since October 29, 2013 contained a smart card which was programmed with an inaccurate lkN2 value.

    • Terminated Z-1518-2011 FDA Unclassified (pre-2012) initiated 17 Dec 2010

    Certain LICOX CMP Tissue Oxygen Monitors could allow for underestimation of temperature values.

    • Terminated Z-0622-05 FDA Unclassified (pre-2012) initiated 21 Jan 2005 on shared 510(k) K002765

    LICOX Model C8.B temperature probes manufactured by GMS mbH, an Integra company, may exhibit progen (endotoxin) levels above the FDA limit of 2.15 endotoxin units per device. Elevated endotoxin levels may result in an increased patient risk of fever.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GWM
Device Class
Class II
Regulation
21 CFR Part 882.1620
Advisory Committee
Neurology
FDA Decision
SESE Substantially Equivalent

Other devices from Integra Neurosciences

See all devices from Integra Neurosciences →